 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | STEM-PD / Lund University, Novo Nordisk
Preclinical, Journal: Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. (Pubmed Central) - Nov 1, 2023
We further observed highly comparable efficacy results between two different GMP batches, verifying that the product can be serially manufactured. A fully in vivo-tested batch of STEM-PD is now being used in a clinical trial of 8 patients with moderate PD, initiated in 2022.
- | STEM-PD / Lund University, Novo Nordisk
Enrollment open: STEM-PD: A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease (clinicaltrials.gov) - Dec 8, 2022
P1, N=8, Recruiting, Sponsor: Region Skane
A fully in vivo-tested batch of STEM-PD is now being used in a clinical trial of 8 patients with moderate PD, initiated in 2022. Not yet recruiting --> Recruiting